These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1421646

  • 21. Comparison of repeat doses of intramuscular ketorolac tromethamine and morphine sulfate for analgesia after major surgery.
    Brown CR, Mazzulla JP, Mok MS, Nussdorf RT, Rubin PD, Schwesinger WH.
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):45S-50S. PubMed ID: 2082313
    [Abstract] [Full Text] [Related]

  • 22. Renal failure and hyperkalemia associated with ketorolac tromethamine.
    Pearce CJ, Gonzalez FM, Wallin JD.
    Arch Intern Med; 1993 Apr 26; 153(8):1000-2. PubMed ID: 8481061
    [Abstract] [Full Text] [Related]

  • 23. Ketorolac: a parenteral nonsteroidal antiinflammatory drug.
    Resman-Targoff BH.
    DICP; 1990 Nov 26; 24(11):1098-104. PubMed ID: 2275236
    [Abstract] [Full Text] [Related]

  • 24. Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat.
    Chellman GJ, Lollini LO, Dorr AE, DePass LR.
    Hum Exp Toxicol; 1994 Feb 26; 13(2):111-7. PubMed ID: 7908807
    [Abstract] [Full Text] [Related]

  • 25. Ketorolac: a new parenteral nonsteroidal anti-inflammatory drug for postoperative pain management.
    Lassen K, Epstein-Stiles M, Olsson GL.
    J Post Anesth Nurs; 1992 Aug 26; 7(4):238-42. PubMed ID: 1494990
    [Abstract] [Full Text] [Related]

  • 26. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.
    Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H, Kimmel S, Carson JL.
    JAMA; 1996 Feb 07; 275(5):376-82. PubMed ID: 8569017
    [Abstract] [Full Text] [Related]

  • 27. Intravenous ketorolac tromethamine versus morphine sulfate in the treatment of immediate postoperative pain.
    Peirce RJ, Fragen RJ, Pemberton DM.
    Pharmacotherapy; 1990 Feb 07; 10(6 ( Pt 2)):111S-115S. PubMed ID: 2082306
    [Abstract] [Full Text] [Related]

  • 28. Ketorolac-induced bronchospasm in an aspirin-intolerant patient.
    Chen AH, Bennett CR.
    Anesth Prog; 1994 Feb 07; 41(4):102-7. PubMed ID: 8934961
    [Abstract] [Full Text] [Related]

  • 29. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I.
    Pharmacotherapy; 1990 Feb 07; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [Abstract] [Full Text] [Related]

  • 30. Comparison of ketorolac and meperidine in patients with postoperative pain--impact on health care utilization.
    Stahlgren LR, Trierweiler M, Tommeraasen M, Mehlisch D, Otterson W, Maneatis T, Bynum L, DiGiorgio E.
    Clin Ther; 1993 Feb 07; 15(3):571-80; discussion 570. PubMed ID: 8364949
    [Abstract] [Full Text] [Related]

  • 31. Single-blind comparative analgesic and safety study of single doses of intramuscularly administered ketorolac tromethamine and pethidine hydrochloride in patients with pain following orthopaedic surgery.
    Satku K, Lai FO, Kumar VP, Pereira BP, Chhatwal V.
    Ann Acad Med Singap; 1994 Nov 07; 23(6):828-31. PubMed ID: 7741493
    [Abstract] [Full Text] [Related]

  • 32. Weight gain associated with long-term oral ketorolac tromethamine.
    Parent M, Patrice M.
    Ann Pharmacother; 1994 Feb 07; 28(2):284-5. PubMed ID: 8173156
    [No Abstract] [Full Text] [Related]

  • 33. A double-blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate.
    Diebschlag W, Nocker W, Bullingham R.
    J Clin Pharmacol; 1990 Jan 07; 30(1):82-9. PubMed ID: 2105985
    [Abstract] [Full Text] [Related]

  • 34. Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers.
    Lucker P, Bullingham R, Hooftman L, Lloyd J, Mroszczak E.
    Int J Clin Pharmacol Ther; 1994 Aug 07; 32(8):409-14. PubMed ID: 7981925
    [Abstract] [Full Text] [Related]

  • 35. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G, Rivolta R, Bottoni G, Testa B, Canali S, Peano S.
    Farmaco; 1993 Dec 07; 48(12):1709-23. PubMed ID: 8135994
    [Abstract] [Full Text] [Related]

  • 36. Ketorolac-induced bronchospasm.
    Zikowski D, Hord AH, Haddox JD, Glascock J.
    Anesth Analg; 1993 Feb 07; 76(2):417-9. PubMed ID: 8424524
    [No Abstract] [Full Text] [Related]

  • 37. Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain.
    Gordon RL.
    Ann Pharmacother; 1998 Feb 07; 32(2):193-6. PubMed ID: 9496404
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D, Mroszczak E, Bynum L.
    Eur J Clin Pharmacol; 1988 Feb 07; 35(4):423-5. PubMed ID: 3264245
    [Abstract] [Full Text] [Related]

  • 39. The pharmacologic activity of ketorolac tromethamine.
    Rooks WH.
    Pharmacotherapy; 1990 Feb 07; 10(6 ( Pt 2)):30S-32S. PubMed ID: 2082310
    [Abstract] [Full Text] [Related]

  • 40. Ketorolac-induced acute renal failure and hyperkalemia: report of three cases.
    Haragsim L, Dalal R, Bagga H, Bastani B.
    Am J Kidney Dis; 1994 Oct 07; 24(4):578-80. PubMed ID: 7942813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.